149 related articles for article (PubMed ID: 2435558)
1. Haemodilution therapy in ischaemic stroke: plasma concentrations and plasma viscosity during long-term infusion of dextran 40 or hydroxyethyl starch 200/0.5.
Kroemer H; Haass A; Müller K; Jäger H; Wagner EM; Heimburg P; Klotz U
Eur J Clin Pharmacol; 1987; 31(6):705-10. PubMed ID: 2435558
[TBL] [Abstract][Full Text] [Related]
2. [Dextran 40 or HES 200/0.5? Hemorheology of the long-term treatment of ischemic cerebral attacks].
Haass A; Kroemer H; Jäger H; Müller K; Decker I; Wagner EM; Schimrigk K
Dtsch Med Wochenschr; 1986 Oct; 111(44):1681-6. PubMed ID: 2429818
[TBL] [Abstract][Full Text] [Related]
3. Effect of hypervolaemic haemodilution of regional cerebral blood flow in patients with acute ischaemic stroke: a controlled study with hydroxyethylstarch.
Hartmann A; Tsuda Y; Lagrèze H
J Neurol; 1987 Oct; 235(1):34-8. PubMed ID: 2448425
[TBL] [Abstract][Full Text] [Related]
4. Influence of low molecular weight hydroxyethyl starch (HES 40/0.5-0.55) on hemostasis and hemorheology.
Treib J; Haass A; Pindur G; Grauer MT; Seyfert UT; Treib W; Wenzel E; Schimrigk K
Haemostasis; 1996; 26(5):258-65. PubMed ID: 8894656
[TBL] [Abstract][Full Text] [Related]
5. [Effect of a 10% and 6% hydroxyethyl starch solution (molecular weight 200,000/0.62) in comparison with a 10% dextran solution (molecular weight 40,000) on flow properties of blood and tissue oxygen pressure in patients with intermittent claudication].
Ehrly AM; Seebens H; Saeger-Lorenz K
Infusionstherapie; 1988 Oct; 15(5):181-7. PubMed ID: 2461906
[TBL] [Abstract][Full Text] [Related]
6. [Hemorheologic effects of hydroxyethyl starch 200/0.5, dextran 40, oxypolygelatine and full electrolyte solution over 48 hours].
Brehme S; Keysser G; Turowski A; Schmidt HH
Z Gesamte Inn Med; 1993 Oct; 48(10):506-10. PubMed ID: 7504854
[TBL] [Abstract][Full Text] [Related]
7. Influence of intravenous infusions of hydroxyethylstarch (HES) (MW 40,000 and 450,000) on the blood flow properties of healthy volunteers.
Ehrly AM; Landgraf H
Angiology; 1985 Jan; 36(1):41-4. PubMed ID: 2411169
[TBL] [Abstract][Full Text] [Related]
8. Haemodilution in acute ischaemic stroke comparison of two haemodilution regimen.
Staedt U; Holm E; Leweling H; Heene DL
Neurol Res; 1992; 14(2 Suppl):152-5. PubMed ID: 1355875
[TBL] [Abstract][Full Text] [Related]
9. [Continuous hemodilution using a low-molecular hydroxyethyl starch solution. Pilot studies in patients with acute cerebral ischemia].
Fuchs M; Henkel P; Becker-Scheid D; Schmitt J
Infusionstherapie; 1990 Aug; 17(4):205-9. PubMed ID: 1698719
[TBL] [Abstract][Full Text] [Related]
10. [Comparative study of low molecular dextran or hydroxyethyl starch as a volume substitute in hemodilution therapy].
Kiesewetter H; Jung F; Blume J; Bulling B; Franke RP
Klin Wochenschr; 1986 Jan; 64(1):29-37. PubMed ID: 2419635
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the effects of infusion with hydroxyethyl starch and low molecular weight dextran on cerebral blood flow and hemorheology in normal baboons.
Tsuda Y; Hartmann A; Weiand J; Solymosi L
J Neurol Sci; 1987 Dec; 82(1-3):171-80. PubMed ID: 2450177
[TBL] [Abstract][Full Text] [Related]
12. [Hemorheologic changes in preoperative hemodilution during total hip replacement. Randomized study comparing hydroxyethyl starch 200,000/0.62 (HES) and a dextran 60,000].
Lartigue B; Barre J; Nguyen P; Potron G
J Mal Vasc; 1994; 19(1):27-31. PubMed ID: 7517991
[TBL] [Abstract][Full Text] [Related]
13. [Organ blood supply and oxygenation during limited isovolemic hemodilution with 6% HES 200/0.62 and 6% Dextran 70].
Brückner UB; Messmer K
Anaesthesist; 1991 Aug; 40(8):434-40. PubMed ID: 1719841
[TBL] [Abstract][Full Text] [Related]
14. The effect of In vitro hemodilution with gelatin, dextran, hydroxyethyl starch, or Ringer's solution on Thrombelastograph.
Petroianu GA; Liu J; Maleck WH; Mattinger C; Bergler WF
Anesth Analg; 2000 Apr; 90(4):795-800. PubMed ID: 10735778
[TBL] [Abstract][Full Text] [Related]
15. All medium starches are not the same: influence of the degree of hydroxyethyl substitution of hydroxyethyl starch on plasma volume, hemorrheologic conditions, and coagulation.
Treib J; Haass A; Pindur G; Grauer MT; Wenzel E; Schimrigk K
Transfusion; 1996 May; 36(5):450-5. PubMed ID: 8693511
[TBL] [Abstract][Full Text] [Related]
16. [Hemodilution in the treatment of cerebrovascular disorders].
Mendel T; Członkowska A
Neurol Neurochir Pol; 1991; 25(2):247-54. PubMed ID: 1717868
[TBL] [Abstract][Full Text] [Related]
17. [Comparison of 2 6% middle-molecular hydroxyethyl starch solutions on elimination kinetics and flow characteristics of blood in volunteers].
Koscielny J; Jung F; Mrowietz C; Pindur G; Förster H; Schimetta W; Kiesewetter H; Wenzel E
Infusionsther Transfusionsmed; 1994 Aug; 21(4):251-9. PubMed ID: 7524833
[TBL] [Abstract][Full Text] [Related]
18. [Hemodilution in patients with stage IIb peripheral arterial occlusive disease: prospective randomized double-blind comparison of middle-molecular weight hydroxyethyl starch and low-molecular weight dextran solution].
Kiesewetter H; Jung F; Blume J; Gerhards M
Klin Wochenschr; 1987 Apr; 65(7):324-30. PubMed ID: 2438451
[TBL] [Abstract][Full Text] [Related]
19. Bioequivalence comparison between hydroxyethyl starch 130/0.42/6 : 1 and hydroxyethyl starch 130/0.4/9 : 1.
Lehmann G; Marx G; Förster H
Drugs R D; 2007; 8(4):229-40. PubMed ID: 17596109
[TBL] [Abstract][Full Text] [Related]
20. Treatment of cerebral ischemia with Dextran-40 or Fluosol DA 20%.
Kline RA; Negendank W; McCoy LE
Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):979-83. PubMed ID: 1382645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
